All AbMole products are for research use only, cannot be used for human consumption.
Pimozide is an antagonist of 6-hydroxyapatide against 6-hydroxyapatide, with Ki values of 1.4 nM, 2.5 nM and 588 nM for 6-hydroxyapatide, D3 and D1 receptors, respectively. Pimozide also has a high affinity for α1-adrenoceptor. Ki value is 39 nM. Pimozide is also an inhibitor of STAT3 and STAT5, and piperimidate triggers ADCD in glioblastoma cell lines (LN-229, MZ-54, GOS-3 and U343) by inducing dephosphorylation and inactivation of mTORC1.
| Molecular Weight | 461.55 |
| Formula | C28H29F2N3O |
| CAS Number | 2062-78-4 |
| Solubility (25°C) | DMSO 10 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Jussara Maria Gonalves, et al. Inhibition of cancer stem cells promoted by Pimozide
[2] Robert Smyj, et al. Pimozide
[3] Tamara Pringsheim, et al. Pimozide for tics in Tourette's syndrome
[4] J Rathbone, et al. Pimozide for schizophrenia or related psychoses
| Related Dopamine Receptor Products |
|---|
| AJ-76
AJ-76 ((+)-AJ 76; (1S,2R)-AJ 76) is a dopamine autoreceptor antagonist. |
| A-412997
A-412997 is a selective Dopamine D4 agonist with Ki values of 12 and 7.9 nM for the rat and human receptors. |
| SKF 81297
SKF 81297 is a potent and selective dopamine D1 receptor agonist. |
| GBR 12783
GBR 12783 is a specific, potent and selective dopamine uptake inhibitor that inhibits the [3H]dopamine uptake by rat and mice striatal synaptosomes with IC50s of 1.8 nM and 1.2 nM, respectively. |
| RMI-61140
RMI-61140 is an orally active neuroleptics. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
